ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,188Medicare Part D Prescriptions Filled, Including Refills

Rank: 118 out of 944

$520K Total Retail Price of All Prescriptions

Rank: 198 out of 944

402 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 402 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 402 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 10,987 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
WARFARIN SODIUM 761 756 1 7
LEVOTHYROXINE SODIUM 543 543 2 2
FUROSEMIDE 499 494 3 6
OMEPRAZOLE 342 339 4 4
FENTANYL 319 318 S2 5 57
DONEPEZIL HCL 283 283 6 24
AMLODIPINE BESYLATE 281 281 7 5
LISINOPRIL 250 243 8 3
SIMVASTATIN 238 230 9 1
MIRTAZAPINE 206 206 10 35
TRAMADOL HCL 180 180 11 21
SPIRONOLACTONE 164 163 12 44
NAMENDA 160 160 13 37
GABAPENTIN 158 149 14 18
HYDROCODONE-ACETAMINOPHEN 157 155 S3 15 10
METOPROLOL TARTRATE 151 143 16 8
SERTRALINE HCL 135 135 17 23
METHADONE HCL 133 133 S2 18 134
POTASSIUM CHLORIDE 123 121 19 15
CARBIDOPA-LEVODOPA 123 122 19 77
CLOPIDOGREL 112 112 21 36
QUETIAPINE FUMARATE 107 107 22 69
RANITIDINE HCL 103 103 23 42
KLOR-CON M20 97 97 24 71
ATENOLOL 92 91 25 11
CARVEDILOL 91 91 26 30
KLOR-CON M10 91 89 26 122
GLIMEPIRIDE 90 90 28 47
POLYETHYLENE GLYCOL 3350 89 88 29 41
LIDODERM 87 87 30 73
HUMALOG 86 80 31 109
PANTOPRAZOLE SODIUM 84 84 32 34
EXELON 82 82 33 149
LANTUS SOLOSTAR 80 80 34 61
PREDNISONE 77 76 35 32
METOPROLOL SUCCINATE 77 77 35 14
FAMOTIDINE 74 74 37 74
PLAVIX 73 73 38 55
DIVALPROEX SODIUM 73 73 38 85
TAMSULOSIN HCL 72 72 40 27
METFORMIN HCL 69 69 41 12
BACLOFEN 68 62 42 111
LANTUS 66 65 43 46
TRIAMTERENE-HCTZ 66 66 43 33
LOSARTAN POTASSIUM 66 66 43 16
LEVETIRACETAM 64 64 46 97
CITALOPRAM HBR 64 63 46 19
DILTIAZEM 24HR CD 63 63 48 124
NYSTATIN 63 63 48 134
VENLAFAXINE HCL ER 63 63 48 84
DIGOXIN 62 62 51 39
ESCITALOPRAM OXALATE 61 61 52 98
HYDROCHLOROTHIAZIDE 56 56 53 9
ATORVASTATIN CALCIUM 53 53 54 13
LOPERAMIDE 53 53 54 211
ISOSORBIDE MONONITRATE ER 52 46 56 52
CYMBALTA 51 33 57 75
IPRATROPIUM-ALBUTEROL 51 51 57 101
CLONIDINE HCL 50 50 59 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 20, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.